Data de publicação: 02/06/2020 - 09:40
João Aprígio Guerra de Almeida champions social mobilization to promote the use of donated breast milk for infants who cannot be breastfed directly by their mothers. The driving force behind the Rede Brasileira de Bancos de Leite Humano (Brazilian Network of Human Milk Banks), he is also the executive secretary of the Programa Ibero-Americano de Bancos de Leite Humano (Ibero-American Program of Human Milk Banks). In recognition of...
Notícias
Data de publicação: 01/06/2020 - 16:56
The Fiocruz against Covid-19 will benefit, all over the country, 145 projects that focus on vulnerable populations, such as quilombos (rural afro-brazilian settlements), indigenous peoples, riverside populations and favela dwellers. The initiative reaches more than 80 municipalities in all Brazilian states. The projects were selected through a Public Call for Support to Emergency Actions against Covid-19 in Vulnerable Populations...
Notícias
Data de publicação: 27/05/2020 - 11:58
In 2016, for the first time in Latin America, Brazil was the epicenter of a Public Health Emergency of International Concern. The unusual increase in babies born with microcephaly and other neurological disorders initially attracted the attention of bedside doctors in the Northeast; months later, the world looked at the country and its babies with concern.
This was clearly a public health emergency, but it demanded a coordinated and...
Notícias
Data de publicação: 26/05/2020 - 14:34
Fiocruz celebrates its 120th anniversary this Monday, May 25. The date comes right when Brazil and the world are facing the biggest public health, economical, social, humanitarian and political challenge of the 21st century: the Covid-19 pandemic. The institution was founded with the name Instituto Soroterápico Federal [Federal Soroterapic Institute], with the purpose of fighting epidemics such as the bubonic plague, yellow fever, and...
Notícias
Data de publicação: 25/05/2020 - 18:37
More than 7.8 million Brazilians are at least four hours away from a town where high-complexity healthcare is available, such as an intensive care unit (ICU), suitable equipment and staff specialized in severe and acute respiratory diseases as the one caused by the Covid-19 epidemic. This is one of the main conclusions of the most recent analysis by the Institute of Scientific and Technological Communication and Information in Health (Icict), of...
Notícias
Data de publicação: 25/05/2020 - 15:41
In another step of its actions to combat the pandemic of the new coronavirus, the Oswaldo Cruz Foundation (Fiocruz) built in less than two months a hospital unit for severe patients infected by the disease. Located in Manguinhos, headquarters of the Foundation in Rio de Janeiro, the Hospital Center for Pandemic Covid-19 - National Institute of Infectious Diseases Evandro Chagas (INI / Fiocruz) started receiving, on May 19, the first patients....
Notícias
Data de publicação: 20/05/2020 - 16:57
The animation Carlos Chagas, which features the paths taken by the scientist until the discovery of Chagas disease, has just got a version in English. Available on the Internet, the episode is part of the series, Ciência em Gotas (Science in Drops), an initiative of the Casa de Oswaldo Cruz (COC/Fiocruz), which features the journey of Brazilian scientists with relevant activities in the field of public health and the environment. The...
Notícias
Data de publicação: 20/05/2020 - 16:28
The Institute of Drug Technology (Farmanguinhos/Fiocruz) has started the production of the first generic drug in the country to treat chronic liver infection caused by the hepatitis B virus (HBV). It is the Entecavir 0.5 mg, an antiviral drug that aims to reduce the risk of disease progression in patients and its complications, such as cirrhosis, liver cancer and even death.
The production is the result of a cooperation with the Ezequiel...
Notícias
Data de publicação: 14/05/2020 - 14:19
A research led by the Oswaldo Cruz Institute (IOC/Fiocruz) points out that the circulation of the novel coronavirus (SARS-CoV-2) started up to four weeks before the first cases were registered in countries in Europe and the Americas. The study, which uses a statistical methodology of inference from death records, indicates that, while countries were monitoring travelers and confirming the first imported Covid-19 cases, community transmission of...
Notícias
Data de publicação: 29/04/2020 - 12:19
Published in the JAMA Network Open, the initial results of the CloroCovid-19 trial show that patients with severe Covid-19 should not take high doses of chloroquine. The trial, whose goal is to assess the efficacy of two different dosages of the drug and has analised 81 patients with SARS (severe acute respiratory syndrome), is being led by more than 70 researchers, post-graduation students, and collaborators from renowned scientific...
Notícias
Data de publicação: 28/04/2020 - 19:01
The Oswaldo Cruz Foundation (Fiocruz) will be producing 11 million tests for the Ministry of Health (MS) by September. The Foundation began supplying the tests on March 4. The goal of the first agreement was to produce 25,000 tests for Sars-CoV-2, to be used in the National Influenza Centers (Oswaldo Cruz Institute - IOC/Fiocruz, Adolfo Lutz Institute and Evandro Chagas Institute).
Also in March, as the number of cases associated to the...
Notícias
Data de publicação: 28/04/2020 - 18:43
The number of deaths caused by Covid-19 has doubled every 5 days in Brazil, on average. In the United States and in Ecuador, countries with high dissemination rates, the interval necessary for this duplication is an average of 6 days. In Italy and in Spain, 8 days.
This is one of the figures released by the most recent technical paper of MonitoraCovid-19, a system that groups and provides data on the pandemic of the new coronavirus in...
Notícias
Data de publicação: 28/04/2020 - 17:59
A group of researchers of the Oswaldo Cruz Foundation (Fiocruz) and of the Getulio Vargas Foundation (FGV) has just released a report on the risk of Covid-19 dissemination among indigenous populations, due to the geographic and sociodemographic vulnerability of this segment of the Brazilian population. According to the study, the arrival of Covid-19 has imposed many challenges to indigenous communities, to health authorities and to society as a...
Notícias
Data de publicação: 17/04/2020 - 14:29
Enhancing the actions of the Oswaldo Cruz Foundation (Fiocruz) in the view of the new coronavirus pandemic (Sars-CoV-2) by joining the forces of the public and private sectors. This is the goal of the United against Covid-19 program launched by Fiocruz on April 2nd, opening a channel for companies, organizations and individuals interested in being a part of the network of supporters for the initiatives developed by the institution, all over...
Notícias
Data de publicação: 15/04/2020 - 11:18
With the aim of presenting innovative initiatives to respond to the pandemic, researchers from the Foundation participated, on March 31, in a virtual workshop with Portuguese-speaking countries, organized by the Research Capacity Network (REDe) and the sharing knowledge base incorporated into the online platform The Global Health Network, from the University of Oxford. The platform aims to provide research resources, courses and other tools...
Notícias
Data de publicação: 14/04/2020 - 14:25
On this Tuesday, April 14th is celebrated for the first time as the World Chagas Day, after being recognized in 2019 by the World Health Organization (WHO). To mark the day that remembers the first case diagnosed in humans by Fiocruz researcher Carlos Chagas, in 1909, leaders of Global Health have prepared a video.
It is estimated that 6 to 7 million people worldwide suffer from Chagas disease, between 2 and 3 million of them live in Brazil....
Notícias
Data de publicação: 14/04/2020 - 09:51
The Laboratory for Respiratory Viruses and Measles of the Oswaldo Cruz Institute (IOC/Fiocruz) has been nominated Reference Laboratory of the World Health Organization (WHO) for Covid-19 in the Americas. After the formalization of the agreement between the WHO and Fiocruz, the unit will now begin making confirmatory tests for the disease in the region, and will also join the WHO network of laboratory specialists for Covid-19.
National...
Notícias
Data de publicação: 09/04/2020 - 16:00
A Fiocruz research has observed that the drug Atazanavir, used against HIV, was able to inhibit viral replication and to reduce the production of proteins that are related to the inflammatory process in the lungs, and therefore to the worsening of the clinical symptoms of the disease. Specialists have also looked into the combined use of atazanavir and ritonavir, another drug used to fight HIV.
The study was published this Monday (April 6) on...
Notícias
Data de publicação: 06/04/2020 - 12:38
Fiocruz president, Nísia Trindade Lima, attended last Wednesday (April 1st) a meeting of global health leaders requested by the director-general of the World Health Organization, Tedros Adhanom. The goal of the meeting was to discuss the advancement of control measures in different countries, share lessons learned, and, mainly, debate future challenges involving the Covid-19 pandemic.
The role of WHO in a post-quarantine transition was...
Notícias
Data de publicação: 06/04/2020 - 12:19
Fiocruz is now part of a group of more than 70 scientists and institutions of more than 30 countries in an international coalition to face the Covid-19 epidemic in countries with medium and low income. Launched last Thursday (02/04), the initiative, called Covid-19 Clinical Resarch Coalition, aims to speed up research on the new coronavirus in the areas where the virus may cause serious problems in health systems that are already fragile,...
Notícias
Data de publicação: 31/03/2020 - 14:34
The Foundation started the construction, in Rio de Janeiro, of the Hospital Center for the Covid-19 Pandemic - National Institute of Infectious Diseases, which will assist the state and municipal governments in fighting the disease. The rapid assembly hospital unit will have 200 beds exclusive for intensive and semi-intensive treatment of critical patients infected with the novel coronavirus (Sars-CoV-2). Check out a 3D view here.
Built in...
Notícias
Data de publicação: 31/03/2020 - 13:18
On March 24, the Oswaldo Cruz Foundation launched an express approval process at the Brazilian Registry of Clinical Essays (ReBEC) for clinical research on the Covid-19. The so-called fast track may reduce the normal approval period, which normally takes up to a couple of weeks, to less than 48 hours. Scientists all over the world will be able to have quick access to the modeling of ongoing studies, thus avoiding re-working and...
Notícias
Data de publicação: 31/03/2020 - 12:52
In an interview to the Fiocruz News Agency (AFN), Nísia Trindade Lima comments on the context of the Covid-19 pandemics and the challenges of its arrival in Brazil. The Fiocruz president also lists some of the actions taken by the institution as a response to this public health crisis, from the production of tests to health care to those infected. All departments and units of the Foundation are mobilized to face the epidemics....
Notícias
Data de publicação: 30/03/2020 - 14:04
An unprecedented study, conducted by the research group on Health in the Prisions [Saúde nas Prisões] of the National School of Public Health (Ensp/Fiocruz), and coordinated by Alexandra Sánchez, through technical cooperation with the Public Prosecutor's Office/RJ, analyzed the causes of deaths in the Prison System of the State of Rio de Janeiro (2016-2017). The results indicate that infectious diseases were...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
